OverviewChartNewsTraderScreen

BVT Call 165 ABBV 21.06.2024/  DE000VM0AAB6  /

Frankfurt Zert./VONT
30/05/2024  10:23:09 Chg.-0.002 Bid12:12:19 Ask12:12:19 Underlying Strike price Expiration date Option type
0.057EUR -3.39% 0.053
Bid Size: 11,000		 0.063
Ask Size: 11,000		 AbbVie Inc 165.00 USD 21/06/2024 Call
GlobeNewswire 29/05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 28/05 Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Imp...
GlobeNewswire 28/05 CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...
GlobeNewswire 28/05 Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
GlobeNewswire 25/05 CERE (NASDAQ) ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation; Contact BFA Law ...
GlobeNewswire 24/05 Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...
GlobeNewswire 23/05 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire 22/05 Over 130 Resident Dermatologists Receive In-Depth Cosmetic Training From Renowned ASDS Member Physic...
GlobeNewswire 22/05 Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $57...
GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 22/05 Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $57...
GlobeNewswire 22/05 Anavex Life Sciences Announces Expansion of Leadership Team
GlobeNewswire 22/05 OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...
GlobeNewswire 21/05 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
GlobeNewswire 21/05 BREAKING CEREVEL INVESTIGATION: BFA Law Is Investigating the $45 Per CERE (Nasdaq) Share Offer by Ab...
GlobeNewswire 21/05 Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire 17/05 INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 16/05 Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
GlobeNewswire 14/05 CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire 14/05 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 14/05 In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit
GlobeNewswire 13/05 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 11/05 SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC